Clinical trial · Interventional
Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors
Narrating Their Story: Shadow's Edge Mobile Game Use to Enhance Resilience and Identity Formation Among Adolescent and Young Adult Survivors of Cancer
NCT04218682CI-TRIAL-00082585completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the efficacy of an interactive mobile game, Shadow's Edge, on enhancing resilience, promoting identity development, and decreasing somatic symptoms among adolescent and young adult survivors of cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Shadow's Edge Mobile Application Gameplay | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Immediate Game Use
- description
- AYACS randomly assigned to this arm will immediately play the Shadow's Edge Game following enrollment for a duration of 7 weeks. Following the designated 7-week game-play period, they will continue to have access to the game. They will continue to receive all usual care health care throughout and following the study.
- interventionNames
- Behavioral: Shadow's Edge Mobile Application Gameplay
- type
- NO_INTERVENTION
- label
- Wait-List Comparison Group
- description
- AYACS randomly assigned to this arm will begin to play the Shadow's Edge game 7 weeks following enrollment. They will continue to receive all usual health care throughout and following the study.
Primary outcomes (1)
- measure
- Resilience
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 13 Years
- Maximum age
- 24 Years
Show eligibility criteria text
Inclusion Criteria: * Adolescent/young adults 13-24 years of age * Adolescent/young adult English-speaking at a second grade level * Parent/guardian English- or Spanish-speaking at a second grade level (for participants younger than 18 years of age) * Patients with history of hematological malignancies (e.g., acute lymphoblastic leukemia) at maintenance phase of treatment or beyond or solid tumor patients (e.g., osteosarcoma) who have completed active treatment or cancer survivors with any form of malignancy history (excluding brain tumors) and are at least 2 years post-diagnosis of the malignancy * Consistent access to a mobile phone and/or internet service Exclusion Criteria: * Brain tumor history * History of moderate to severe neurodevelopmental disorder (e.g., autism spectrum disorder)
References
Publications (0)
Data not yet available
No reference posted for this study.